UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031856
Receipt number R000036378
Scientific Title Current status of antibiotics and immunotherapy for severe infections
Date of disclosure of the study information 2018/04/01
Last modified on 2020/04/26 09:18:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Current status of antibiotics and immunotherapy for severe infections

Acronym

Current status of antibiotics and immunotherapy for severe infections

Scientific Title

Current status of antibiotics and immunotherapy for severe infections

Scientific Title:Acronym

Current status of antibiotics and immunotherapy for severe infections

Region

Japan


Condition

Condition

severe infections

Classification by specialty

Medicine in general Intensive care medicine Adult
Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to examine the efficacy and side effects of IVIG administration for patients with severe infectious diseases.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ICU mortality rate, ICU treatment period, side effect

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 days-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Between January 1, 2008 and March 30, 2020, we entered the intensive care unit of our hospital and a patient diagnosed as severe infection

Key exclusion criteria

When the research subject is refused to participate

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Mao
Middle name
Last name Kinoshita

Organization

Kyoto Prefectural University of Medicine

Division name

Anesthesiology

Zip code

6028566

Address

465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, japan

TEL

0752515633

Email

mao6515@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Mao
Middle name
Last name Kinoshita

Organization

Kyoto Prefectural University of Medicine

Division name

Anesthesiology

Zip code

6028566

Address

465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, japan

TEL

0752515633

Homepage URL


Email

mao6515@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto Prefectural University of Medicine

Address

465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, japan

Tel

0752515633

Email

mao6515@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 01 Day

Date of IRB

2018 Year 06 Month 05 Day

Anticipated trial start date

2018 Year 06 Month 06 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A retrospective observation study will investigate whether there is an effect of improving prognosis for severe infections in our intensive care unit.


Management information

Registered date

2018 Year 03 Month 23 Day

Last modified on

2020 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036378


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name